Neurothera Labs Inc
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$5.42M
-0.01
Neurothera Labs Inc. operates as a specialty clinical-stage pharmaceutical company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-07-19. The firm is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in various drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation, and SCI- 210 for the treatment of ASD and status epilepticus.
Neurothera Labs Inc. operates as a specialty clinical-stage pharmaceutical company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-07-19. The firm is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in various drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation, and SCI- 210 for the treatment of ASD and status epilepticus.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.